

Oncology/Genetics
Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients globally. We also offer a rapid test that detects the genetic risk for thrombosis.
Products

Xpert® BCR-ABL Ultra
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Xpert® BCR-ABL Ultra p190
Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)

Xpert® Bladder Cancer Detection
Detection of the presence of bladder cancer in patients with hematuria in 90 minutes

Xpert® Bladder Cancer Monitor
Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in 90 minutes

Xpert® Breast Cancer STRAT4
Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours
